Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug:107:238-246.
doi: 10.1016/j.bjps.2025.06.007. Epub 2025 Jun 7.

First experience from 200 cases with a new breast tissue expander for multi-stage pre-pectoral breast reconstruction after mastectomy

Affiliations
Free article

First experience from 200 cases with a new breast tissue expander for multi-stage pre-pectoral breast reconstruction after mastectomy

E Limido et al. J Plast Reconstr Aesthet Surg. 2025 Aug.
Free article

Abstract

Background: Breast cancer is the most common cancer globally, and mastectomy rates are increasing. Tissue expander-based breast reconstruction is used when direct-to-implant methods are unsuitable. A novel magnetic resonance imaging compatible breast tissue expander has recently been introduced. This study aims to evaluate its clinical use in pre-pectoral breast reconstruction and its complication profile.

Methods: A monocentric prospective cohort study included women undergoing expander-based breast reconstruction after mastectomy with the new tissue expander between August 2020 and October 2024. The expanders were placed in a pre-pectoral plane with optional use of acellular dermal matrices in selected cases. Demographic data, comorbidities, and surgical details were analyzed. Tissue expander-independent and -dependent complications were assessed.

Results: A total of 200 tissue expanders were implanted in 146 patients (92 unilateral, 54 bilateral). Major complications requiring expander replacement included infection (3.0%), partial necrosis of the mastectomy flap (2.5%), wound dehiscence (1.0%), hematoma (1.0%), and seroma (0.5%). Tissue expander rotation and/or flipping, as well as iatrogenic rupture, occurred in 2% and 3.5% of all cases. Definitive removal was required in ten cases, mainly due to mastectomy flap necrosis and wound dehiscence with or without expander exposure (2.5%), as well as infection (2.0%).

Discussion: The new breast tissue expander features a biocompatible surface that does not adhere to adjacent tissues and therefore needs fixation alongside the inframammary fold, particularly if used in the pre-pectoral plane, contributing to a low complication rate. While short-term results are promising, long-term follow-up on a larger scale is needed to confirm these outcomes.

Keywords: Biocompatibility; Breast cancer; Breast tissue expander; Composite breast reconstruction; Mastectomy; Multi-staged pre-pectoral breast reconstruction.

PubMed Disclaimer

LinkOut - more resources